| Outcome Measures: |
Primary: Mean Change from Baseline in HbA1c (Tirzepatide 10 or 15 milligram [mg]), Baseline, Week 40 | Secondary: Mean Change from Baseline in HbA1c (Tirzepatide 5 mg), Baseline, Week 40|Mean Change from Baseline in Body Weight, Baseline, Week 40|Percentage of Participants with HbA1c <7.0% (53 millimole/mole [mmol/mol]) and ≤6.5% (48 mmol/mol), Week 40|Mean Change from Baseline in Fasting Serum Glucose, Baseline, Week 40|Percentage of Participants with HbA1c <5.7% (39 mmol/mol) [Tirzepatide 10 mg or 15 mg], Week 40|Percentage of Participants with HbA1c <5.7% (39 mmol/mol) [Tirzepatide 5 mg], Week 40|Mean Change from Baseline in Daily Average 7-point Self-monitored Blood Glucose Profiles, Baseline, Week 40|Percentage of Participants Who Achieved Weight Loss of ≥5%, Week 40|Percentage of Participants Who Achieved Weight Loss of ≥10%, Week 40|Percentage of Participants Who Achieved Weight Loss of ≥15%, Week 40|Percentage Change from Baseline in Daily Mean Insulin Glargine Dose, Baseline, Week 40|Percentage of Participants with HbA1c <7.0%, Without Weight Gain (<0.1 kilogram [kg]) and Without Hypoglycemia, (Blood glucose <3.0 mmol/L <54 milligram/deciliter [mg/dL]), Week 40|Percentage of Participants with HbA1c ≤6.5%, Without Weight Gain <0.1 kg and Without Hypoglycemia (Blood glucose <3.0 mmol/L [54 mg/dL]), Week 40|Percentage of Participants with HbA1c <7.0%, Without Weight Gain <0.1 kg and Without Hypoglycemia (Blood glucose <3.9 mmol/L [70 mg/dL] or Severe hypoglycemia), Week 40|Percentage of Participants with HbA1c ≤6.5%, Without Weight Gain <0.1 kg and Without Hypoglycemia (Blood glucose <3.9 mmol/L [70 mg/dL] or Severe Hypoglycemia), Week 40
|
| Locations: |
The Second People's Hospital of Hefei, Hefei, Anhui, 230011, China|Beijing Hospital, Beijing, Beijing, 100005, China|Beijing Pinggu District Hospital, Beijing, Beijing, 101200, China|Chongqing General Hospital, Chongqing, Chongqing, 400014, China|Huizhou Municipal Central Hospital, Huizhou, Guangdong, 516001, China|The First Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China|The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China|The First Affiliated Hospital of Henan University of Science &Technology, LuoyangShi, Henan, 471003, China|The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450014, China|The First People's Hospital of Yueyang, Yueyang, Hunan, 414000, China|Baotou Central Hospital, Baotou, Inner Mongolia, 014040, China|Changzhou No.2 People's Hospital, Changzhou, Jiangsu, 213000, China|Nanjing First Hospital, Nanjing, Jiangsu, 210006, China|Zhongda Hospital Southeast University, Nanjing, Jiangsu, 210009, China|The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210011, China|The Affiliated Jiangyin Hospital of Southeast University Medical College, WuxiShi, Jiangsu, 214400, China|Wuxi People's Hospital, Wuxi, Jiangsu, 214023, China|Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China|The Third Hospital of Nanchang, Nanchang, Jiangxi, 330009, China|The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, 710077, China|Jinan Central Hospital, Jinan, Shandong, 250013, China|West China Hospital of Sichuan University, ChengDu, Sichuan, 610041, China|Chengdu Fifth People's Hospital, Chengdu, Sichuan, 611130, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300052, China|Huzhou Central Hospital, Huzhou, Zhejiang, 313000, China
|
